Lamb Weston, Inc. agreed on November 11, 2026 to pay $25 million into a fund assisting residents affected by alleged excessive groundwater nitrate levels, subject to court approval and without admitting liability.
LW · Lamb Weston Holdings, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Lamb Weston Holdings, Inc. entered a transition and separation agreement with Marc Schroeder, who will remain President, International through December 31, 2026 and serve as an adviser until February 15, 2027; he resigned without cash severance payments.
Lamb Weston reported first-quarter net sales of $1,670,000,000, up 1%, and adjusted EBITDA of $286 million, down 5%; it raised fiscal 2027 net sales outlook to low single-digit growth and adjusted EPS guidance to $3.05 to $3.35.
Lamb Weston Holdings, Inc. reported net sales of $1,670.3 million and net income of $29.1 million for the first quarter of fiscal 2027; North America Segment Adjusted EBITDA increased 11%, while International decreased (54)%.
Lamb Weston Holdings, Inc. reported fiscal first quarter 2027 net sales of $1.67 billion, up 1% year-over-year, and Adjusted Diluted EPS of $0.75. Fiscal 2027 Adjusted EBITDA guidance increased to $1.125 billion to $1.215 billion.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q4 FY26 earnings call · Jul 24, 2026TL;DR. Lamb Weston delivered FY26 net sales of $6,612M and adjusted EBITDA of $1,147M, both exceeding the high end of guidance, but full-year adjusted EBITDA still fell 9% year-over-year as International segment EBITDA plunged 55%. For FY27, the company guided to flat-to-up 1% net sales and adjusted EBITDA of $1.1B–$1.2B, while announcing a Dutch plant closure and an ongoing strategic review of its international footprint.
- + North America delivered six consecutive quarters of volume growth with Q4 segment adjusted EBITDA up 17% to $305M
- + Cost savings program exceeded its $100M year-one milestone, with a target of at least $250M annualized run-rate by FY28
- + Free cash flow jumped to $537M as capex fell more than $240M year-over-year
- + Company returned $321M to shareholders and declared a $0.38 quarterly dividend
- + FY27 adjusted EPS guided to $2.95–$3.25 vs. $2.90 52-week comparable, with earnings expected to grow faster than sales
- − Q4 inflation ran higher than expected, with substantial increases in edible oils and transportation, carrying into Q1 FY27
- − FY27 guidance points to flat-to-up 1% net sales and International revenue down low single digits, with Q1 EBITDA expected to decline in the low teens
- − Company is closing a Dutch facility representing about 10% of EMEA production capacity amid regional overcapacity
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $0.75 | Q1 2027 | — |
GAAP → non-GAAP reconciliationGAAP Diluted EPS $0.21
+$0.01 Unrealized derivative gains and losses
+$0.08 Foreign currency exchange losses
+$0.09 Stock-based compensation
+$0.18 Cost Savings Program, Restructuring Plan, and other expenses
+$0.18 Legal proceedings and other claims
= Adjusted Diluted EPS $0.75
|
|||
| Adjusted EBITDA non-GAAP | $286M | Q1 2027 | — |
| Adjusted Gross Profit non-GAAP | $316.8M | first quarter of fiscal 2027 filing | — |
GAAP → non-GAAP reconciliationGAAP Gross Profit 266.5M
-0.6M Unrealized derivative gains and losses
+0M Foreign currency exchange gains and losses
+0M Stock-based compensation
+20.1M Cost Savings Program, Restructuring Plan, and other expenses
+30.8M Legal proceedings and other claims
= Adjusted Gross Profit 316.8M
|
|||
| Adjusted Income Tax Expense non-GAAP | $38.5M | Thirteen Weeks Ended August 30, 2026 filing | — |
| Adjusted Net Income non-GAAP | $103M | Q1 2027 | — |
GAAP → non-GAAP reconciliationGAAP Net Income 29.1M
+0.6M Unrealized derivative gains and losses
+10.2M Foreign currency exchange losses
+12.6M Stock-based compensation
+25.3M Cost Savings Program, Restructuring Plan, and other expenses
+25.1M Legal proceedings and other claims
= Adjusted Net Income 102.9M
|
|||
| Adjusted SG&A non-GAAP | $139.2M | first quarter of fiscal 2027 filing | — |
GAAP → non-GAAP reconciliationGAAP Selling, General and Administrative 170.2M
-1.3M Unrealized derivative gains and losses
-12.4M Foreign currency exchange gains and losses
-15.1M Stock-based compensation
+0M Cost Savings Program, Restructuring Plan, and other expenses
-2.2M Legal proceedings and other claims
= Adjusted SG&A 139.2M
|
|||
| Equity method investment earnings | $6.2M | Thirteen Weeks Ended August 30, 2026 filing | — |
| International Segment Adjusted EBITDA non-GAAP | $27M | Q1 2027 | — |
| Net Sales excluding FX non-GAAP | $1.67B | Thirteen Weeks Ended August 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Sales 1.67B
-4.1M FX
= Net sales excluding FX 1.67B
|
|||
| North America Segment Adjusted EBITDA non-GAAP | $287M | Q1 2027 | — |
| Segment Adjusted EBITDA non-GAAP | $313.8M | the thirteen weeks ended August 30, 2026 filing | — |
| Segment Adjusted EBITDA - International non-GAAP | $26.5M | Thirteen Weeks Ended August 30, 2026 | — |
| Segment Adjusted EBITDA - North America non-GAAP | $287.3M | Thirteen Weeks Ended August 30, 2026 | — |
| Unallocated corporate costs non-GAAP | -$28.2M | Thirteen Weeks Ended August 30, 2026 | — |
| Adjusted Equity Method Investment Earnings non-GAAP | $7.5M | fiscal year ended May 31, 2026 filing | — |
| McDonald's Corporation share of consolidated net sales | 15% | fiscal 2026 filing | — |
| Net Sales excluding FX and Extra Week non-GAAP | $6.36B | Fifty-Three Weeks Ended May 31, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net Sales $6.61B
-$123.1M FX
-$127.1M Extra Week
= Net Sales excluding FX and Extra Week $6.36B
|
|||
| Number of production facilities | 25 | fiscal 2026 filing | — |
| Segment Adjusted EBITDA excluding Extra Week non-GAAP | $1.12B | Fifty-Three Weeks Ended May 31, 2026 filing | — |
GAAP → non-GAAP reconciliationSegment Adjusted EBITDA $1.15B (non-GAAP)
-$28.9M Extra Week
= Segment Adjusted EBITDA excluding Extra Week $1.12B
|
|||
| ten largest customers as a percentage of net sales | 50% | fiscal 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LW
this stock
Lamb Weston Holdings, Inc.
|
$7.72B | +33.8% | +2.5% | 30.6 | 6.1% |
|
JBS
Jbs N.V.
|
$40.00B | -15.7% | — | — | 1.3% |
|
KHC
Kraft Heinz Co
|
$29.73B | +3.5% | -0.1% | — | 8.7% |
|
GIS
General Mills Inc
|
$18.35B | -26.2% | +4.1% | — | 7.0% |
|
SJM
J M SMUCKER Co
|
$14.17B | +35.7% | +3.7% | — | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 12, 2026
- This year
- 20
Lamb Weston, Inc. agreed on November 11, 2026 to pay $25 million into a fund assisting residents affected by alleged excessive groundwater nitrate levels, subject to court approval and without admitting liability.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LW | +1.5% | +4.6% | +33.1% | +3.7% | +33.8% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -1.1% | +5.8% | +32.6% | +3.8% | +23.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.